PharmaCielo Ltd. (OTCMKTS:PCLOF) Short Interest Update

PharmaCielo Ltd. (OTCMKTS:PCLOF) was the target of a significant growth in short interest in the month of March. As of March 13th, there was short interest totaling 70,220 shares, a growth of 25.0% from the February 26th total of 56,169 shares. Based on an average trading volume of 117,284 shares, the short-interest ratio is currently 0.6 days.

PharmaCielo Price Performance

PCLOF stock opened at $0.04 on Monday. PharmaCielo has a twelve month low of $0.00 and a twelve month high of $0.12. The business’s 50-day moving average price is $0.05 and its 200-day moving average price is $0.04.

About PharmaCielo

PharmaCielo (OTCMKTS:PCLOF) is a Colombia-based, vertically integrated cannabinoid extraction and manufacturing company that develops pharmaceutical-grade active ingredients for the global medical cannabis market. The company specializes in the cultivation, extraction, purification and isolation of cannabinoids, producing a range of high-purity oils, distillates and isolates that serve as the active pharmaceutical ingredients (APIs) in end-use formulations. PharmaCielo’s product portfolio is designed to meet Good Manufacturing Practices (GMP) standards, enabling partnerships with pharmaceutical firms and wellness brands seeking compliant, consistently standardized cannabinoid inputs.

Since commencing operations, PharmaCielo has established a state-of-the-art extraction facility in Colombia, leveraging the country’s favorable agronomic conditions and regulatory framework for medicinal cannabis cultivation.